Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine

NCT06241313 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1300

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Atogepant
DRUG: Placebo for Atogepant

Sponsor

AbbVie